RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE

      Geriatric functional assessment for decisionmaking on adjuvant chemotherapy in older colon cancer patients

      한글로보기

      https://www.riss.kr/link?id=A108107431

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background/Aims: Despite the increasing need for geriatric assessment prior to chemotherapy, the method for this assessment remains inadequate for older cancer patients. We aimed to propose a simple assessment method to predict the performance of adju...

      Background/Aims: Despite the increasing need for geriatric assessment prior to chemotherapy, the method for this assessment remains inadequate for older cancer patients. We aimed to propose a simple assessment method to predict the performance of adjuvant chemotherapy in older patients after colon cancer surgery.
      Methods: This prospective study included patients over 65 years of age who were scheduled for adjuvant chemotherapy after colon cancer surgery. Before initiating chemotherapy, their functional status was assessed on the basis of activities of daily living (ADL)/instrumental activities of daily living (IADL). These parameters were analyzed with clinical characteristics and the patterns of adjuvant chemotherapy. The focus was on the completion rate of adjuvant chemotherapy.
      Results: A total of 89 patients with a median age of 72 years were analyzed. Among them, 54 (61%) were non-impaired and 35 (39%) were impaired regarding their ADL/IADL classification. Low body mass index and impairment of ADL/IADLs were significantly associated with chemotherapy interruption. Among toxicities, fatigue and hand-foot syndrome were independent prognostic factors for chemotherapy interruption. Impairments of ADL/IADL were significantly associated with fatigue regardless of age. Based on age and ADL/IADL stratification, younger patients (≤ 72 years) and/or those who were ADL/IADL non-impaired were significantly more likely to complete adjuvant chemotherapy than older patients (> 72 years) and ADL/IADL impaired patients (p = 0.038). This was regardless of the chemotherapy regimen.
      Conclusions: Functional assessment using ADL/IADL is a convenient method to predict chemotherapy toxicity and performance.
      These results suggested that routine screening for ADL/IADLs could guide appropriate patient selection for the completion of adjuvant chemotherapy and predict expected outcomes.

      더보기

      참고문헌 (Reference)

      1 Extermann M, "Use of comprehensive geriatric assessment in older cancer patients : recommendations from the task force on CGA of the International Society of Geriatric Oncology(SIOG)" 55 : 241-252, 2005

      2 Bouchardy C, "Undertreatment strongly decreases prognosis of breast cancer in elderly women" 21 : 3580-3587, 2003

      3 Papamichael D, "Treatment of colorectal cancer in older patients : International Society of Geriatric Oncology(SIOG)consensus recommendations 2013" 26 : 463-476, 2015

      4 Hamaker ME, "The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer" 17 : 1439-1449, 2012

      5 Green SL, "The use of chemotherapy in older patients with stage II and III colon cancer : variation by age and era of diagnosis" 10 : 132-137, 2019

      6 Won CW, "The development of Korean activities of daily living(K-ADL)and Korean instrumental activities of daily living(K-IADL)scale" 6 : 107-120, 2002

      7 Katz S, "Studies of illness in the aged : the index of ADL : a standardized measure of biological and psychosocial function" 185 : 914-919, 1963

      8 Surveillance, Epidemiology, and End Results, "SEER Cancer Statics Review, 2013-2017" SEER

      9 Bruijnen CP, "Predictive value of each geriatric assessment domain for older patients with cancer : a systematic review" 10 : 859-873, 2019

      10 Extermann M, "Predicting the risk of chemotherapy toxicity in older patients : the Chemotherapy Risk Assessment Scale for High-Age Patients(CRASH)score" 118 : 3377-3386, 2012

      1 Extermann M, "Use of comprehensive geriatric assessment in older cancer patients : recommendations from the task force on CGA of the International Society of Geriatric Oncology(SIOG)" 55 : 241-252, 2005

      2 Bouchardy C, "Undertreatment strongly decreases prognosis of breast cancer in elderly women" 21 : 3580-3587, 2003

      3 Papamichael D, "Treatment of colorectal cancer in older patients : International Society of Geriatric Oncology(SIOG)consensus recommendations 2013" 26 : 463-476, 2015

      4 Hamaker ME, "The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer" 17 : 1439-1449, 2012

      5 Green SL, "The use of chemotherapy in older patients with stage II and III colon cancer : variation by age and era of diagnosis" 10 : 132-137, 2019

      6 Won CW, "The development of Korean activities of daily living(K-ADL)and Korean instrumental activities of daily living(K-IADL)scale" 6 : 107-120, 2002

      7 Katz S, "Studies of illness in the aged : the index of ADL : a standardized measure of biological and psychosocial function" 185 : 914-919, 1963

      8 Surveillance, Epidemiology, and End Results, "SEER Cancer Statics Review, 2013-2017" SEER

      9 Bruijnen CP, "Predictive value of each geriatric assessment domain for older patients with cancer : a systematic review" 10 : 859-873, 2019

      10 Extermann M, "Predicting the risk of chemotherapy toxicity in older patients : the Chemotherapy Risk Assessment Scale for High-Age Patients(CRASH)score" 118 : 3377-3386, 2012

      11 Hurria A, "Predicting chemotherapy toxicity in older adults with cancer : a prospective multicenter study" 29 : 3457-3465, 2011

      12 Mohile SG, "Practical assessment and management of vulnerabilities in older patients receiving chemotherapy : ASCO guideline for geriatric oncology summary" 14 : 442-446, 2018

      13 Andre T, "Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer" 350 : 2343-2351, 2004

      14 National Comprehensive Cancer Network, "NCCN Clinical Practice Guidelines for specific populations: Older Adult Oncology (version 1.2020)" NCCN

      15 Wildiers H, "International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer" 32 : 2595-2603, 2014

      16 Inouye SK, "Importance of functional measures in predicting mortality among older hospitalized patients" 279 : 1187-1193, 1998

      17 Haller DG, "Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer : a pooled analysis of individual patient data from four randomized, controlled trials" 26 : 715-724, 2015

      18 Aparicio T, "Geriatric factors predict chemotherapy feasibility : ancillary results of FFCD 2001-02phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients" 31 : 1464-1470, 2013

      19 SanoffHK, "Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years" 30 : 2624-2634, 2012

      20 Martin L, "Diagnostic criteria for the classification of cancer-associated weight loss" 33 : 90-99, 2015

      21 Cheung WY, "Determinants of early mortality among 37, 568 patients with colon cancer who participated in 25 clinical trials from the adjuvant colon cancer endpoints database" 34 : 1182-1189, 2016

      22 Li D, "Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy" 144 : 909-923, 2018

      23 Haller DG, "Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer" 29 : 1465-1471, 2011

      24 Twelves C, "Capecitabine as adjuvant treatment for stage III colon cancer" 352 : 2696-2704, 2005

      25 Fabi A, "Cancer-related fatigue:ESMO Clinical Practice Guidelines for diagnosis and treatment" 31 : 713-723, 2020

      26 National Cancer Center, "Cancer statistics reports for Korea" NCC

      27 Lee DW, "Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients : results from the AVANT trial" 10 : 19467-, 2020

      28 Lawton MP, "Assessment of older people : self-maintaining and instrumental activities of daily living" 9 : 179-186, 1969

      29 Kim JW, "A novel geriatric screening tool in older patients with cancer : the Korean Cancer Study Group Geriatric Score(KG)-7" 10 : e0138304-, 2015

      30 Health Insurance Review & Assessment Service, "7th Colon cancer assessment report" HIRA

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.37 0.26 1.02
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.83 0.73 0.566 0.13
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼